Evaluation of Jarro-Dophilus EPS® Probiotic Formulations
Completed · Not applicable · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to determine the effects of the two doses of Jarro-Dophilus EPS® probiotic supplements on fecal lactobacillus and bifidobacteria numbers, transit survival of administered probiotic strains, fecal microbiota, gastrointestinal function and general wellbeing in healthy human adults.
Key facts
- Study ID
- NCT02693314
- Run by
- University of Florida
- People needed
- 75
- Starts
- 2016-03-01
- Expected to finish
- 2016-04-01
- Last updated by the study team
- 2018-03-23
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- To participate in the study you must
- be between18-50 years of age
- be willing to have your height and weight measured and provide demographic information
- be willing to consume a probiotic or placebo capsule daily for 4 weeks
- be willing to provide 3 stool samples during the study
- be willing to complete a daily questionnaires regarding general and gastrointestinal wellness and the Gastrointestinal Symptom Rating Scale weekly throughout the entire 6-wk study
- have daily access to a computer with Internet access for the entire 6-wk study
- be willing and able to provide a valid social security for study payment purposes
- be willing and able to provide a valid social security for study payment purposes
- be willing to complete the International Physical Activity Questionnaire (asks you to report physical activity including intensity, duration and frequency)
You may not qualify if…
- To participate in the study you must NOT
- be currently taking medications for constipation or diarrhea
- have previously or are you currently being treated for any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's, Celiac, ulcerative colitis, etc.), other chronic diseases (diabetes, kidney disease, etc.) or immune-compromising diseases or conditions (HIV, AIDS, autoimmune, hepatitis, cancer, transplant patient etc.)
- have any known allergy to milk, milk protein, soy, gluten or have gluten sensitivity
- have taken antibiotics within the past 4 weeks prior to randomization
- be currently taking a probiotic supplement and are unwilling to discontinue it a minimum of 2 weeks prior to the study start
- be a current smoker.
Where it is running
- Food Science and Human Nutrition Department, University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.